Synergy CHC (SNYR) Interest & Investment Income (2016 - 2025)

Synergy CHC's (SNYR) quarterly Interest & Investment Income came in at $379.0 in Q2 2025, up 1.34% year-on-year from $374.0 in Q2 2024, and down 97.27% quarter-over-quarter from $13882.0 in Q1 2025.

Synergy CHC (SNYR) Interest & Investment Income (2016 - 2025) Analysis & Trends

Synergy CHC's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $379.0 for Q2 2025.

  • On a quarterly basis, Interest & Investment Income rose 1.34% year-over-year to $379.0 in Q2 2025; TTM through Jun 2025 was $15022.0, a 1547.15% increase from a year earlier, with the FY2025 full-year figure at $15065.0, up 889.17% from the prior year.
  • Interest & Investment Income eased to $379.0 in Q2 2025 per SNYR's latest filing, from $13882.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $13882.0 in Q1 2025 and bottomed at $374.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Mckesson 105.15 Bn 101.18 Bn 4.04 Bn -
2 Cencora 60.58 Bn 58.40 Bn 3.59 Bn -
3 Cardinal Health 53.81 Bn 49.87 Bn 2.50 Bn -
4 Henry Schein 9.71 Bn 9.57 Bn 1.07 Bn 7.00 Mn
5 Akso Health 3.28 Bn 3.28 Bn - -
6 111 651.73 Mn 572.63 Mn 23.58 Mn 133,000.00
7 Accendra Health 248.02 Mn -88.86 Mn 278.03 Mn -
8 Edap Tms 230.14 Mn 215.14 Mn 8.15 Mn -
9 VitaNova Life Sciences 11.51 Mn 11.01 Mn 316,343.00 -
10 Synergy CHC 1.63 Mn -1.09 Mn 2.22 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 379.00
Mar 31, 2025 13,882.00
Jun 30, 2024 374.00
Mar 31, 2024 387.00
Mar 31, 2020 66.00
Dec 31, 2019 85.00
Sep 30, 2019 105.00
Jun 30, 2019 113.00
Mar 31, 2019 111.00
Dec 31, 2018 114.00
Sep 30, 2018 50.00
Jun 30, 2018 -1,011.00
Mar 31, 2018 1,082.00
Dec 31, 2017 814.00
Sep 30, 2017 -784.00
Jun 30, 2017 5.00
Mar 31, 2017 -15.00
Dec 31, 2016 -64.00
Sep 30, 2016 -370.00
Jun 30, 2016 -749.00